Your trusted destination for CME, CPD & Medical Education across the Middle East.
Prince Sultan Medical Military City
Dr. Khalid J. Hundallah is a prominent Saudi Consultant Pediatric Neurologist with extensive clinical, academic, research, and professional leadership experience. He is based at Prince Sultan Military Medical City (PSMMC) in Riyadh, where he serves as a Consultant Pediatric Neurologist and has held senior departmental leadership responsibilities. The Saudi Pediatric Neurology Society identifies him as Chairman of the Paediatric Department at Prince Sultan Medical Military City and Vice President of the Saudi Pediatric Neurology Society.
His professional career has focused on pediatric neurological disorders, particularly epilepsy, epileptic encephalopathies, neurogenetic diseases, leukodystrophies, neurometabolic disorders, and other complex neurological conditions affecting children. His research record includes work on rare inherited neurological disorders as well as national clinical practice guidelines and consensus recommendations.
Dr. Hundallah's publicly documented professional qualifications include MD and MRCPCH. The official 2023 Saudi Pediatric Neurology Society conference material lists him as:
Dr. Khalid Hundallah, MD, MRCPCH, Consultant Pediatric Neurology, Prince Sultan Medical Military City, and Vice President of the Saudi Pediatric Neurology Society.
A historical Neurosciences publication also documents that he completed Pediatric Neurology training at McMaster University in Hamilton, Ontario, Canada.
Public conference biography material additionally states that he completed a pediatric neurology fellowship at McMaster University.
Dr. Hundallah has held several significant positions within Saudi pediatric neurology:
His continued participation in SPNS activities has placed him among the senior pediatric neurologists involved in national specialty education and professional development in Saudi Arabia.
One of Dr. Hundallah's important professional contributions has been his involvement in the development of Saudi pediatric neurology training and curriculum standards.
The Saudi Commission for Health Specialties' Saudi Board Pediatric Neurology Curriculum lists Dr. Khalid Hundallah as a member of the Curriculum Scientific Group and the Pediatric Neurology Scientific Committee responsible for reviewing and approving the curriculum.
He also remained involved in the 2025 revision of the Saudi Board Pediatric Neurology Curriculum. The revised curriculum lists him among the members of the Curriculum Scientific Group and the Pediatric Neurology Scientific Council responsible for review and approval.
This represents an important contribution to the standardization and development of specialist pediatric neurology training in Saudi Arabia.
Dr. Hundallah has held a prominent leadership role within the Saudi Pediatric Neurology Society.
The SPNS identifies him as Vice President, and he has participated in several of the society's major annual conferences.
At the 8th Annual SPNS Conference in 2023, he served as Chairman of the Scientific Committee.
He subsequently served as a senior organizing/scientific committee member for later SPNS conferences, including the 9th, 10th and 11th conferences.
His involvement demonstrates sustained leadership in continuing medical education and professional development within pediatric neurology in Saudi Arabia.
Dr. Hundallah has contributed to research and clinical literature covering several important areas of pediatric neurology.
He contributed to research examining early-onset epileptic encephalopathy caused by KCNA2 mutations.
A reported cohort included 11 children with severe early-onset epileptic encephalopathy, refractory seizures, developmental delay, and abnormal EEG findings. The study reported significant clinical and electroencephalographic improvement in 9 of 11 patients (81%) following treatment with acetazolamide.
This work contributes to understanding potential treatment approaches for rare genetic epileptic encephalopathies.
Dr. Hundallah was an author of the 2016 publication “Sulfite oxidase deficiency,” published in Neurosciences (Riyadh).
The article addressed this rare inherited metabolic disorder, reflecting his involvement in the diagnosis and clinical understanding of uncommon pediatric neurometabolic diseases.
He also authored the 2017 article “Pantothenate kinase-associated neurodegeneration,” published in Neurosciences.
The condition, also known as PKAN, is a rare neurodegenerative disorder associated with abnormal iron accumulation in the brain. His publication reflects his involvement in reporting and educating clinicians about rare pediatric neurodegenerative conditions.
Dr. Hundallah was a co-author of the multicenter Saudi study “Acute Necrotizing Encephalopathy of Childhood: A Multicenter Experience in Saudi Arabia,” published in Frontiers in Pediatrics.
The study involved multiple Saudi pediatric neurology and related centers and investigated the clinical characteristics and outcomes of acute necrotizing encephalopathy in children.
He also contributed to the large multicenter study “The Leukodystrophy Spectrum in Saudi Arabia: Epidemiological, Clinical, Radiological, and Genetic Data.”
The study examined the epidemiology, clinical presentation, imaging findings, and genetic characteristics of leukodystrophies in Saudi Arabia, contributing to the country's growing literature on inherited white-matter disorders.
Dr. Hundallah was a co-author of “2020 Update to Spinal Muscular Atrophy Management in Saudi Arabia,” a national update addressing the diagnosis and management of spinal muscular atrophy.
His affiliation in the publication was the Division of Neurology, Department of Pediatrics, Prince Sultan Military Medical City, Riyadh.
He contributed to the Gulf Cooperation Council expert consensus statement on the diagnosis and management of infantile epileptic spasms syndrome (IESS).
The consensus brought together pediatric neurology experts from GCC countries to address diagnosis and treatment of this serious early-life epilepsy syndrome. Dr. Hundallah is listed as an author with his affiliation at Prince Sultan Military Medical City.
Dr. Hundallah was also a contributor to the Saudi clinical practice guideline “Management of convulsive status epilepticus in children: an adapted clinical practice guideline for pediatricians in Saudi Arabia.”
The guideline involved experts from Saudi pediatric neurology, pediatrics, emergency medicine, intensive care, pharmacy, and other disciplines. Dr. Hundallah was affiliated with Pediatric Neurology at Prince Sultan Military Medical City and with the Saudi Pediatric Neurology Society.
This work is particularly significant because status epilepticus is a neurological emergency in children requiring rapid, evidence-based management.
Dr. Hundallah has been a recurring faculty member and scientific leader at national and international pediatric neuroscience meetings.
His documented activities include:
Based on his clinical leadership and published research, Dr. Hundallah's professional expertise includes:
Saudi Pediatric Neurology Society (SPNS)
Saudi Pediatric Neurology Society (SPNS)
King Fahad Armed Forces Hospital – Health Services Directorate, Ministry of Defense
King Fahad Armed Forces Hospital – Health Services Directorate, Ministry of Defense